Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 02:15
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 20°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Cover Story]
Low¡æLower¡æMuch Lower Çѱ¹µµ ÅÃÇß´Ù
ÀÌ»óµ· ±âÀÚ
2022-06-03 18:20
[Sub Story]
Ç÷¾Ð¸¸? LDL-Cµµ ÇÔ²²!
ÀÌ»óµ· ±âÀÚ
2022-06-03 18:09
[Drug Review]
3Á¦º¹ÇÕÁ¦·Î °íÀ§Ç豺 ½ÉÇ÷°üÁúȯ ¿¹¹æ±îÁö Á÷Ç×
ÀÌ»óµ· ±âÀÚ
2022-06-03 17:43
[Sub Story]
ÀÌ»óÁöÁúÇ÷Áõ¡¤´ç´¢º´¡¤ºñ¸¸ µ¿¹ÝÀÌȯ º´Å»ý¸®ÀÇ ¼øȯ°í¸®
ÀÌ»óµ· ±âÀÚ
2022-06-03 17:32
[Sub Story]
½ºÅ¸Æ¾/Ç÷´ç°ÇÏÁ¦ SPC Á¦Á¦ ±â´ë°¨ »ó½Â
ÀÌ»óµ· ±âÀÚ
2022-06-03 17:27
¶óÀÎ
[Sub Story]
°íÇ÷¾Ð Ä¡·á¿¡¼ 3Á¦º¹ÇÕÁ¦ÀÇ ¿ªÇÒ°ú ÇýÅÃ
THE MOST
2022-06-03 17:10
[Sub Story]
LDL-C »ó½Â¼¼ »êºÒ·Î ¹øÁö±â Àü Á¦¾ÐÇؾß
ÀÌ»óµ· ±âÀÚ
2022-06-03 16:03
[Sub Story]
55mg/dL ¹Ì¸¸Á¶Àý ±¹³» ùµîÀå È®½Ç½Ã
ÀÌ»óµ· ±âÀÚ
2022-06-03 15:54
[Sub Story]
½ºÅ¸Æ¾ ½ÉÇ÷°üÁúȯ 1¡¤2Â÷¿¹¹æÀÇ ±â·Ï
ÀÌ»óµ· ±âÀÚ
2022-06-03 15:46
[Sub Story]
¸ñǥġ ³»·Á°¥¼ö·Ï º´¿ëÄ¡·á´Â Áõ°¡
ÀÌ»óµ· ±âÀÚ
2022-06-03 15:23
¶óÀÎ
[Interview]
Àú¿ë·®½ºÅ¸Æ¾/¿¡Á¦Æ¼¹Ìºê ÃʱâÄ¡·á °¡´É¼º ºÃ´Ù
ÀÌ»óµ· ±âÀÚ
2022-06-03 15:07
[Sub Story]
¾È¹æ ³»Áֱ⠽ȴٴ °íÁß¼ºÁö¹æÇ÷Áõ!
ÀÌ»óµ· ±âÀÚ
2022-06-03 14:54
[Sub Story]
Áß¼ºÁö¹æ °Á¦Åð°Å½ÃÅ°·Á¸é?
ÀÌ»óµ· ±âÀÚ
2022-06-03 14:49
[Interview]
¡°Áß¼ºÁö¹æ, ASCVD °ü¸®ÀÇ ÇÙ½ÉÀÎÀÚ¡±
ÀÓ¼¼Çü ±âÀÚ
2022-06-03 14:44
[Primary Expert Opinion]
2022 ÀÌ»óÁöÁúÇ÷Áõ Áø·á ¾î¶»°Ô ´Þ¶óÁö³ª
THE MOST
2022-06-03 14:36
¶óÀÎ
[Interview]
¡°Á¦Çü ÁÙÀÎ ¿À¸Þ°¡-3Áö¹æ»êÀ¸·Î ¼øÀÀµµ¡¤Èí¼öÀ² °³¼± ±â´ë¡±
ÀÓ¼¼Çü ±âÀÚ
2022-06-03 14:30
[Conference Report]
±Þº¯ÇÏ´Â ´ç´¢º´ °ü¸®Àü·« ¼Ó ¾ÈÁ¤Àû LDL-C¡¤Ç÷´ç °ü¸®°¡ ÇÙ½É
ÀÓ¼¼Çü ±âÀÚ
2022-06-03 14:16
[Conference Report]
Àú¿ë·® ½ºÅ¸Æ¾ + ¿¡Á¦Æ¼¹Ìºê ½ºÅ¸Æ¾ °í¿ë·®°ú À¯»çÇÑ È¿°ú È®ÀÎ
ÀÓ¼¼Çü ±âÀÚ
2022-06-03 14:04
[Conference Report]
¡°isCGM ÀÓ»óÇýÅÃ, ¸®¾ó¿ùµå ±Ù°Å¿¡¼ È®Àεȴ١±
ÀÓ¼¼Çü ±âÀÚ
2022-06-03 13:51
[Late Breaking Studies]
¾ÆÅ丣¹Ù½ºÅ¸Æ¾/¿À¸Þ°¡-3Áö¹æ»ê °íÁß¼ºÁö¹æÇ÷Áõ À§Çè Àâ´Â´Ù
ÀÓ¼¼Çü ±âÀÚ
2022-06-03 13:39
-
1
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top